MedPath

Implementation of PrEP Care Among Women in Family Planning Clinics

Not Applicable
Not yet recruiting
Conditions
HIV
Prevention
PrEP Uptake
Registration Number
NCT06335121
Lead Sponsor
Rush University Medical Center
Brief Summary

This study will evaluate implementation strategies to address barriers and increase uptake of PrEP among Black cisgender women in Planned Parenthood of Illinois (PPIL) health centers.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
250
Inclusion Criteria
  • Eligible participants include ciswomen presenting at a PPIL health center with a positive STI test (syphilis, gonorrhea, or chlamydia) and identified in the EHR using STI testing records and new fields for optimizing support of provider PrEP counseling.
Exclusion Criteria
  • Participants will be excluded if they are not PrEP eligible, have a negative STI test, or are not identified in the EHR.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
PrEP prescriptions among Black women accessing PPIL services and eligible for PrEP.1 month

PrEP eligibility among Black women will be defined based on positive STI test and identified in the EHR using STI testing records and new fields for optimizing support of provider PrEP counseling. Using de-identified patient-level EHR data for eligible women at each clinic within each time point, we will create a dichotomous variable for having received a prescription for PrEP during a given time period.

Secondary Outcome Measures
NameTimeMethod
Receipt of PrEP refills among Black women accessing FP services at 6 months.6 months

Using de-identified patient-level EHR data for eligible patients at each clinic within each time point, we will create a dichotomous variable for receiving refills of prescriptions for PrEP of those with an initial PrEP prescription.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.